Belly Fat May Say More About Heart Failure Risk Than BMI
Belly Fat May Say More About Heart Failure Risk Than BMI
For decades, body mass index has been the default number for talking about weight and health.
It is easy to calculate, easy to compare, and useful for broad public health trends. But when it comes to heart disease — and especially heart failure — researchers are increasingly arguing that BMI leaves out one of the most important pieces of the story: where fat is actually stored.
That shift matters because body fat is not all biologically equal. A growing body of evidence suggests that abdominal fat, particularly visceral fat packed around internal organs, is more closely linked than BMI to inflammation, metabolic dysfunction, and the kinds of changes that help drive heart failure.
In other words, the belly may tell clinicians more than the scale.
Why BMI only goes so far
BMI has always been a blunt tool.
It relates body weight to height, but it does not distinguish between muscle and fat. It does not reveal whether fat is stored under the skin or around the organs. It says nothing about the inflammatory activity of that fat, or whether it sits in places that are especially harmful to the heart and metabolism.
This is why two people with the same BMI can have very different health profiles. One may have relatively low visceral fat, better metabolic function, and good cardiorespiratory fitness. Another may carry a large amount of abdominal fat and a much more adverse inflammatory and cardiovascular burden, even if the BMI is identical.
The supplied literature supports this broader concern. It points to BMI as an incomplete marker of cardiovascular risk because it cannot capture fat distribution or fat quality.
That does not make BMI useless. It simply means it may not be the right lens when the goal is to understand who is moving towards heart failure risk and why.
Why abdominal fat matters more
Not all fat behaves the same way in the body.
Subcutaneous fat, which sits under the skin, is different from visceral fat, which surrounds internal organs in the abdominal cavity. Visceral fat is more metabolically active and more closely linked to chronic low-grade inflammation, insulin resistance, adverse lipid patterns, and vascular dysfunction.
One of the reviews supplied, focused on regional adiposity and heart failure with preserved ejection fraction, reports that waist circumference, waist-to-hip ratio, epicardial fat, and visceral fat are more strongly tied to heart failure risk profiles than subcutaneous fat.
That same review also links regional fat stores to local and systemic inflammation, impaired cardiorespiratory fitness, and adverse cardiac mechanics.
This is important because it shifts the conversation away from weight as a simple quantity and towards fat as a biologically active tissue. The issue is not just how much fat is present, but what kind it is and where it is sitting.
The inflammation connection
One of the strongest reasons abdominal fat may matter more than BMI is that it appears to be more tightly connected to inflammation.
Visceral obesity has been described in cardiovascular epidemiology as more closely tied than BMI to insulin resistance, inflammatory activity and harmful cardiovascular consequences. That helps explain why a person can have a BMI that looks only moderately elevated while still carrying a substantial burden of metabolic and cardiac risk.
Inflammation is particularly relevant in heart failure. It is not merely a secondary feature of the disease. In many cases, it appears to be part of the environment in which heart dysfunction develops and worsens.
The supplied literature includes additional heart failure data showing that inflammatory markers such as C-reactive protein are strongly associated with frailty and more adverse clinical profiles in people who already have heart failure. Although that study is not a direct incident-risk comparison between abdominal fat and BMI, it reinforces the broader point: inflammation matters in heart failure, and abdominal adiposity seems to be one of the tissues most strongly connected to inflammatory signalling.
Why fat location can change what the heart experiences
The body does not merely store abdominal fat. It reacts to it.
When fat accumulates around the abdomen and internal organs, it contributes to a metabolic environment that can affect blood pressure, vascular health, glucose metabolism, and the mechanical demands placed on the heart. Some regional fat depots, such as epicardial fat surrounding the heart itself, may also influence the local cardiac environment more directly.
That is one reason abdominal obesity may be more informative than a total-body measure such as BMI. It reflects a pattern of fat storage that is closely connected to the processes that drive cardiometabolic damage.
This is especially relevant in heart failure with preserved ejection fraction, a condition increasingly recognized as being deeply tied to obesity, inflammation, impaired exercise capacity, and abnormal tissue remodelling.
In that setting, central adiposity is not simply an accompanying feature. It may be part of the disease mechanism.
What this means in real life
For patients and clinicians, the practical implication is fairly straightforward: the number on the BMI chart may not be enough.
Waist circumference and waist-to-hip ratio are simple measures that may add important information about cardiovascular risk. In some research settings, imaging-based measures of visceral fat or epicardial fat offer even more detail, though these are not routine screening tools for the general population.
What this does suggest is that body-fat distribution deserves more attention in everyday clinical assessment, particularly when someone has other signs of cardiometabolic strain — high blood pressure, insulin resistance, elevated blood sugar, poor fitness, or a family history of cardiovascular disease.
In a country such as Canada, where heart failure, obesity, and diabetes are all major public health concerns, this shift in emphasis could be especially important. It moves the conversation away from body size alone and towards a more biologically meaningful understanding of risk.
Why the scale can miss real danger
The broader message is that people can carry significant cardiometabolic risk without necessarily triggering alarm through BMI alone.
Someone may not appear to be at extreme risk based on height and weight, yet still have substantial abdominal adiposity, elevated inflammatory burden, and a physiology moving in the wrong direction. Conversely, another person with a similar BMI may have a very different fat distribution and a less adverse metabolic profile.
That is why clinicians have become increasingly interested in measures that get closer to fat location and function.
This is not about dismissing weight entirely. It is about recognizing that body composition and fat distribution may explain cardiovascular risk better than weight category on its own.
A note of caution
The headline direction is supported by the supplied literature, but the full picture is more nuanced than a single comparison might suggest.
Not all of the studies directly compare belly fat versus BMI in the same prospective design. Much of the evidence is review-based rather than drawn from one definitive trial. And different measures of abdominal adiposity — waist circumference, waist-to-hip ratio, imaging-defined visceral fat, epicardial fat — are not interchangeable.
So the safest conclusion is not that abdominal fat always beats BMI in every setting. It is that regional adiposity appears to provide more informative cardiovascular risk signals in many important contexts, especially where inflammation and heart failure are concerned.
That is a meaningful distinction.
What this means for prevention
If this body of research continues to hold up, the preventive message becomes more focused.
Rather than thinking about weight only as a number to reduce, clinicians and patients may need to pay more attention to central fat accumulation as a sign of cardiometabolic strain. That shifts the conversation from body weight in the abstract to body fat distribution and metabolic health.
The encouraging part is that visceral fat is responsive to intervention. Physical activity, improved diet quality, better sleep, treatment of insulin resistance, and weight loss where appropriate can all help reduce central adiposity.
That means abdominal fat is not just a warning sign. It is also a modifiable one.
The bottom line
The emerging message from this research is not simply that weight matters. It is that where fat is stored may matter more than body weight alone when it comes to heart failure risk and inflammation.
BMI remains useful as a broad screening measure, but it cannot reveal whether someone is carrying the kind of fat most strongly linked to metabolic and cardiovascular harm. Abdominal and visceral fat appear to offer a more informative view of that risk in many settings.
Put simply, the body does not just keep score by kilograms. It also keeps score by where those kilograms are stored. And when that storage is concentrated around the abdomen, the heart may be paying closer attention than the BMI chart can show.